Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2349873 | 0.80 | TRPV4 (0.38) | CYP3A4MAPTNPC1GAASMN1; SMN2 | |
| SCHEMBL2349793 | 0.78 | NFE2L2 (0.33) | CYP3A4MAPTNFE2L2 | |
| SCHEMBL2235124 | 0.77 | CA12 (0.41) | CYP3A4MAPTNPC1GAASMN1; SMN2 | |
| SCHEMBL5658885 | 0.75 | MAPT (0.35) | CYP3A4MAPTKDM4ENFE2L2ALDH1A1 | |
| SCHEMBL28618317 | 0.72 | CYP3A4 (0.30) | CYP3A4MAPT | |
| SCHEMBL2341584 | 0.71 | — | — | |
| SCHEMBL2342052 | 0.71 | — | — | |
| SCHEMBL17514565 | 0.71 | ABL1 (0.39) | CYP3A4MAPTGAAALDH1A1 | |
| SCHEMBL27764030 | 0.71 | HTR2A (0.39) | NPC1GAAKDM4EALDH1A1 | |
| SCHEMBL976785 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101115723-B | Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi | BASF AG (DE) | 2012-02-22 | — | — | CN | disclosed |
| US-8008232-B2 | Such as N-(3',4'-dichlorobiphenyl-2-yl)-5-chloro-1,3-dimethyl-1H-pyrazole-4-carboxamide; seeds | BASF AKTIENGESELLSCHAFT (DE) | 2011-08-30 | — | — | US | disclosed |
| US-20080153707-A1 | Pyrazolecarboxanilides, Process for Their Preparation and Compositions Comprising Them for Controlling Harmful Fungi | BASF AKITENGESELLSCHAFT (DE) | 2008-06-26 | — | — | US | disclosed |
| CN-101115723-A | Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi | BASF AG (DE) | 2008-01-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153707-A1 | Pyrazolecarboxanilides, Process for Their Preparation and Compositions Comprising Them for Controlling Harmful Fungi | CBR3, C1S, PYM1 | CYP3A4 97/4885MAPT 4417/4885NPC1 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.